Assessing patients' knowledge immediately after obtaining the antibacterial drug azithromycin: a community pharmacy-based cross-sectional study
- PMID: 40826368
- PMCID: PMC12359916
- DOI: 10.1186/s13104-025-07447-1
Assessing patients' knowledge immediately after obtaining the antibacterial drug azithromycin: a community pharmacy-based cross-sectional study
Abstract
Objective: This cross-sectional study was conducted across 38 community pharmacies and included 418 patients who were dispensed oral azithromycin. Pharmacists administered a structured questionnaire to collect demographic information and assess patients' knowledge regarding azithromycin use. Knowledge was evaluated based on responses related to the medication's name, dosage, frequency, potential side effects, and intended purpose. Based on their scores, participants were categorized as having poor (< 50%), average (50-70%), or good (> 70%) knowledge. The aim of this study was to assess patients' knowledge of azithromycin use and identify factors influencing their level of understanding.
Results: A total of 418 participants completed the questionnaire, with a mean age of 35.27 years; 75.60% were under 40 years old, and 62.20% were female. The majority were married (81.82%), resided in urban areas (57.89%), and held a university degree (67.70%). Azithromycin was prescribed by physicians for 62.20% of participants, while 29.67% obtained it directly from pharmacists via over-the-counter (OTC) access, and 8.13% self-medicated. Knowledge scores differed significantly according to marital status, place of residence, education level, and socioeconomic status, with higher scores observed among married, urban, university-educated, and higher-income individuals (p < 0.05). In contrast, age, gender, smoking status, and diabetes mellitus showed no significant association with knowledge scores. Overall, 21.53% of participants had poor knowledge, 46.41% had average knowledge, and 32.06% demonstrated good knowledge.
Keywords: Antibacterial drug misuse; Azithromycin; Medication knowledge; Self-medication.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the ethics committee of Port-Said University. Written informed consent was obtained from the study participants after describing the study’s goals and advantages. All study steps were performed in accordance with the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures





Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Investigation and analysis of mental health status of the older adult in western rural areas.Front Public Health. 2025 Jul 16;13:1612600. doi: 10.3389/fpubh.2025.1612600. eCollection 2025. Front Public Health. 2025. PMID: 40740371 Free PMC article.
-
Interventions to reduce non-prescription antimicrobial sales in community pharmacies.Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD013722. doi: 10.1002/14651858.CD013722.pub2. Cochrane Database Syst Rev. 2025. PMID: 39878150
-
Comparison of self-administered survey questionnaire responses collected using mobile apps versus other methods.Cochrane Database Syst Rev. 2015 Jul 27;2015(7):MR000042. doi: 10.1002/14651858.MR000042.pub2. Cochrane Database Syst Rev. 2015. PMID: 26212714 Free PMC article.
-
Pharmacological interventions for those who have sexually offended or are at risk of offending.Cochrane Database Syst Rev. 2015 Feb 18;2015(2):CD007989. doi: 10.1002/14651858.CD007989.pub2. Cochrane Database Syst Rev. 2015. PMID: 25692326 Free PMC article.
References
-
- Contopoulos-Ioannidis DG, et al. Meta-analysis of randomized controlled trials on the comparative efficacy and safety of azithromycin against other antibiotics for lower respiratory tract infections. J Antimicrob Chemother. 2001;48(5):691–703. - PubMed
LinkOut - more resources
Full Text Sources